Breaking News

Wavelength Pharmaceuticals Acquires Majority Stake in Vanamali Organics

Further strengthens its drug substance manufacturing footprint and global supply chain.

Author Image

By: Charlie Sternberg

Associate Editor

Wavelength Pharmaceuticals, a developer and manufacturer of active pharmaceutical ingredients (APIs), has acquired a majority stake in Vanamali Organics Pvt. Ltd. of Telangana, India.   Vanamali is a manufacturer of pharmaceutical key starting materials and advanced drug intermediates, with significant R&D capabilities. The acquisition allows Wavelength to further strengthen its long-standing drug substance manufacturing footprint and global supply chain, as well as its API CDMO business.   ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters